FIVE vs. ANAB
FIVE (Five Below, Inc.) and ANAB (AnaptysBio, Inc.) are both stocks. FIVE operates in Specialty Retail (Consumer Cyclical), while ANAB operates in Biotechnology (Healthcare). Over the past 5 years, FIVE returned 0.91%/yr vs 28.21%/yr for ANAB. At a 0.15 correlation, their price movements are largely independent.
Performance
FIVE vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FIVE achieves a 5.38% return, which is significantly lower than ANAB's 73.48% return.
FIVE
- 1D
- -1.72%
- 1M
- -5.48%
- YTD
- 5.38%
- 6M
- 8.22%
- 1Y
- 57.56%
- 3Y*
- 1.17%
- 5Y*
- 0.91%
- 10Y*
- 16.02%
ANAB
- 1D
- 3.37%
- 1M
- -10.55%
- YTD
- 73.48%
- 6M
- 87.15%
- 1Y
- 259.27%
- 3Y*
- 64.14%
- 5Y*
- 28.21%
- 10Y*
- —
FIVE vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FIVE Five Below, Inc. | 5.38% | 79.46% | -50.76% | 20.52% | -14.51% | 18.24% | 36.85% | 24.96% | 54.28% | 69.49% |
ANAB AnaptysBio, Inc. | 73.48% | 266.16% | -38.19% | -30.88% | -10.82% | 61.63% | 32.31% | -74.53% | -36.67% | 529.50% |
Correlation
The correlation between FIVE and ANAB is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jan 26, 2017 | 0.15 |
Fundamentals
FIVE:
$11.04B
ANAB:
$1.61B
FIVE:
$7.93
ANAB:
-$0.91
FIVE:
2.17
ANAB:
7.11
FIVE:
4.77
ANAB:
126.20
FIVE:
$5.08B
ANAB:
$232.39M
FIVE:
$1.77B
ANAB:
$245.59M
FIVE:
$757.48M
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FIVE vs. ANAB — Risk / Return Rank
FIVE
ANAB
FIVE vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Five Below, Inc. (FIVE) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FIVE | ANAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.32 | ||
| Sortino ratioReturn per unit of downside risk | -1.96 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.53 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 2.34 | 9.28 | -6.94 |
| Martin ratioReturn relative to average drawdown | 9.51 | 22.38 | -12.87 |
Loading charts...
Drawdowns
FIVE vs. ANAB - Drawdown Comparison
The maximum FIVE drawdown since its inception was -76.40%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for FIVE and ANAB.
Loading charts...
Drawdown Indicators
| FIVE | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.40% | -92.08% | +15.68% |
Max Drawdown (1Y)Largest decline over 1 year | -24.71% | -28.15% | +3.44% |
Max Drawdown (3Y)Largest decline over 3 years | -74.13% | -69.32% | -4.81% |
Max Drawdown (5Y)Largest decline over 5 years | -76.40% | -69.32% | -7.08% |
Max Drawdown (10Y)Largest decline over 10 years | -76.40% | — | — |
Current DrawdownCurrent decline from peak | -19.87% | -34.57% | +14.70% |
Average DrawdownAverage peak-to-trough decline | -23.20% | -64.64% | +41.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.07% | 11.64% | -5.57% |
Volatility
FIVE vs. ANAB - Volatility Comparison
Five Below, Inc. (FIVE) has a higher volatility of 17.76% compared to AnaptysBio, Inc. (ANAB) at 12.40%. This indicates that FIVE's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FIVE | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.76% | 12.40% | +5.36% |
Volatility (6M)Calculated over the trailing 6-month period | 29.68% | 46.31% | -16.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.16% | 68.78% | -29.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.95% | 65.31% | -17.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.14% | 75.44% | -29.30% |
Dividends
FIVE vs. ANAB - Dividend Comparison
Neither FIVE nor ANAB has paid dividends to shareholders.
Financials
FIVE vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between Five Below, Inc. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
FIVE and ANAB have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FIVE has higher volatility (17.76%) compared to ANAB (12.40%). In terms of maximum drawdown, FIVE dropped -76.40% vs ANAB's -92.08%.
ANAB currently has the higher Sharpe Ratio (3.80 vs 1.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FIVE and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer